$KFRC
KFORCE INC Stock $kfrc

$kfrc Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000093042024000159 Filed on July 31, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$353.3M	$356.3M
YoY Change	-5.31%	-8.45%
Cost Of Revenue	$254.8M	$257.3M
YoY Change	-5.53%	-7.74%
Gross Profit	$98.57M	$98.97M
YoY Change	-4.73%	-10.24%
Gross Profit Margin	27.9%	27.78%
Selling, General & Admin	$78.31M	$77.72M
YoY Change	-9.18%	-6.36%
% of Gross Profit	79.45%	78.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.543M	$1.555M
YoY Change	28.58%	16.04%
% of Gross Profit	1.57%	1.57%
Operating Expenses	$80.28M	$79.78M
YoY Change	-8.37%	-5.4%
Operating Profit	$18.72M	$19.70M
YoY Change	16.73%	-24.04%
Interest Expense	-$429.0K	-$504.0K
YoY Change	114.5%	61.02%
% of Operating Profit	-2.29%	-2.56%
Other Income/Expense, Net	-$429.0K	-$504.0K
YoY Change	137.02%	61.02%
Pretax Income	$18.29M	$19.20M
YoY Change	15.36%	-25.07%
Income Tax	$4.078M	$5.039M
% Of Pretax Income	22.3%	26.25%
Net Earnings	$14.21M	$14.16M
YoY Change	34.36%	-23.78%
Net Earnings / Revenue	4.02%	3.97%
Basic Earnings Per Share	$0.76	$0.76
Diluted Earnings Per Share	$0.75	$0.75
COMMON SHARES
Basic Shares Outstanding	19.38M shares	19.49M shares
Diluted Shares Outstanding	18.82M shares	18.89M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$127.0K	$110.0K
YoY Change	27.0%	-25.17%
Cash & Equivalents	$127.0K	$110.0K
Short-Term Investments
Other Short-Term Assets	$10.55M	$8.310M
YoY Change	11.08%	-4.95%
Inventory
Prepaid Expenses
Receivables	$229.3M	$230.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$239.9M	$239.1M
YoY Change	-6.97%	-7.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.267M	$8.526M
YoY Change	-12.88%	-63.18%
Goodwill	$25.04M	$25.04M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$48.40M	$45.80M
YoY Change	34.83%	24.93%
Other Assets	$90.61M	$85.39M
YoY Change	26.24%	923.94%
Total Long-Term Assets	$129.9M	$123.6M
YoY Change	16.15%	13.75%
TOTAL ASSETS
Total Short-Term Assets	$239.9M	$239.1M
Total Long-Term Assets	$129.9M	$123.6M
Total Assets	$369.9M	$362.7M
YoY Change	0.02%	-1.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$42.52M	$42.39M
YoY Change	-9.68%	-8.43%
Accrued Expenses	$5.802M	$5.047M
YoY Change	-71.25%	-91.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$116.5M	$102.8M
YoY Change	-2.3%	-1.35%
LONG-TERM LIABILITIES
Long-Term Debt	$26.90M	$36.70M
YoY Change	25.7%	49.19%
Other Long-Term Liabilities	$59.05M	$56.53M
YoY Change	17.78%	9.54%
Total Long-Term Liabilities	$59.05M	$56.53M
YoY Change	17.78%	-25.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$116.5M	$102.8M
Total Long-Term Liabilities	$59.05M	$56.53M
Total Liabilities	$202.5M	$196.1M
YoY Change	6.11%	8.65%
SHAREHOLDERS EQUITY
Retained Earnings	$542.4M	$535.6M
YoY Change	5.01%	4.41%
Common Stock	$735.0K	$735.0K
YoY Change	0.41%	0.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$167.4M	$166.6M
YoY Change
Total Liabilities & Shareholders Equity	$369.9M	$362.7M
YoY Change	0.02%	-1.46%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$14.21M	$14.16M
YoY Change	34.36%	-23.78%
Depreciation, Depletion And Amortization	$1.543M	$1.555M
YoY Change	28.58%	16.04%
Cash From Operating Activities	$30.98M	$20.94M
YoY Change	7.94%	-2.05%
INVESTING ACTIVITIES
Capital Expenditures	$3.522M	$3.104M
YoY Change	220.18%	0.84%
Acquisitions
YoY Change
Other Investing Activities	-$627.0K	$1.756M
YoY Change	4.5%	-1009.84%
Cash From Investing Activities	-$4.149M	-$1.348M
YoY Change	144.06%	-58.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-26.81M	-19.58M
YoY Change	-0.32%	8.03%
NET CHANGE
Cash From Operating Activities	30.98M	20.94M
Cash From Investing Activities	-4.149M	-1.348M
Cash From Financing Activities	-26.81M	-19.58M
Net Change In Cash	17.00K	4.000K
YoY Change	-83.0%	-116.67%
FREE CASH FLOW
Cash From Operating Activities	$30.98M	$20.94M
Capital Expenditures	$3.522M	$3.104M
Free Cash Flow	$27.46M	$17.83M
YoY Change	-0.52%	-2.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Proceeds From Divestiture Of Interest In Joint Venture ProceedsFromDivestitureOfInterestInJointVenture	0	usd
	us-gaap	Proceeds From Divestiture Of Interest In Joint Venture ProceedsFromDivestitureOfInterestInJointVenture	5059000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	182198000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	16210000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4326000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	245000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.36
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	7003000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	10244000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	6000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	185725000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	18574000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4309000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	296000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.36
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	6945000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	14341000	usd
	us-gaap	Net Income Loss NetIncomeLoss	25144000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1461000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	2006000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-17000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	454000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2888000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2574000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6999000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8635000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1848000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1803000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-750000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	993000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-368000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2730000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-19148000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	395000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2461000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	6027000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-8414000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-8665000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-24138000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34105000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	40431000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4979000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4950000	usd
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	2377000	usd
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	usd
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	1150000	usd
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	193000	usd
	kfrc	Receivable Issued To Joint Venture ReceivableIssuedToJointVenture	0	usd
	kfrc	Receivable Issued To Joint Venture ReceivableIssuedToJointVenture	750000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3752000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-834000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	141600000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	342500000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	146500000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	343500000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11229000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	24614000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	14229000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13947000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-10000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30362000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-39571000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	26000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	147000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	8593000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	16547000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2485000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2541000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1097000	usd
	us-gaap	Interest Paid Net InterestPaidNet	233000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1825000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	773000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	406000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	541000	usd
	kfrc	Stock Repurchases Incurred But Not Yet Paid StockRepurchasesIncurredButNotYetPaid	400000	usd
	kfrc	Stock Repurchases Incurred But Not Yet Paid StockRepurchasesIncurredButNotYetPaid	726000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:5pt"><span style="color:#004b8d;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most critical of these estimates and assumptions relate to the following: allowance for credit losses; income taxes; self-insured liabilities for health insurance; and the impairment of goodwill. Although these and other estimates and assumptions are based on the best available information, actual results could be materially different from these estimates. Therefore, our accounting estimates and assumptions may change materially in future periods.</span></div>
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	190000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	270000	shares
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	201000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	192000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	240000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	235000	shares
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	356318000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	98973000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	79777000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19196000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	389190000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	110266000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	84646000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25620000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	708207000	usd
	us-gaap	Gross Profit GrossProfit	194223000	usd
	us-gaap	Operating Expenses OperatingExpenses	159956000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	34267000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	795187000	usd
	us-gaap	Gross Profit GrossProfit	224242000	usd
	us-gaap	Operating Expenses OperatingExpenses	176264000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	47978000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	356318000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	389190000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	708207000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	795187000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1106000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-17000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	105000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	984000	usd
CY2024Q2	kfrc	Accounts Receivable Allowance For Credit Loss Allowance Unrelated To Trade Receivables AccountsReceivableAllowanceForCreditLossAllowanceUnrelatedToTradeReceivables	700000	usd
CY2023Q4	kfrc	Accounts Receivable Allowance For Credit Loss Allowance Unrelated To Trade Receivables AccountsReceivableAllowanceForCreditLossAllowanceUnrelatedToTradeReceivables	500000	usd
CY2024Q2	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	45803000	usd
CY2023Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	40389000	usd
CY2024Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	22468000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	16434000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14323000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14368000	usd
CY2024Q2	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	539000	usd
CY2023Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	658000	usd
CY2024Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2253000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	4075000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	85386000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	75924000	usd
CY2024Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	40300000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	37600000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	42392000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	42842000	usd
CY2024Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	6962000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	5927000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5047000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8699000	usd
CY2024Q2	kfrc	Accrued Rebate Liability Current AccruedRebateLiabilityCurrent	3958000	usd
CY2023Q4	kfrc	Accrued Rebate Liability Current AccruedRebateLiabilityCurrent	7327000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	58359000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	64795000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	33276000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	28110000	usd
CY2024Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	3576000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	3727000	usd
CY2024Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2134000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1705000	usd
CY2024Q2	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	603000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	426000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39589000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	33968000	usd
CY2024Q2	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	44325000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	42025000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12190000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12275000	usd
CY2024Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	19000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	24000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	56534000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54324000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3500000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7000000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4300000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8600000	usd
CY2024Q2	kfrc	Supplemental Unemployment Benefits On Change In Control SupplementalUnemploymentBenefitsOnChangeInControl	30400000	usd
CY2024Q2	kfrc	Supplemental Unemployment Benefits On No Change In Control SupplementalUnemploymentBenefitsOnNoChangeInControl	11500000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000930420-24-000159-index-headers.html	Edgar Link	pending
0000930420-24-000159-index.html	Edgar Link	pending
0000930420-24-000159.txt	Edgar Link	pending
0000930420-24-000159-xbrl.zip	Edgar Link	pending
exhibit311q22024.htm	Edgar Link	pending
exhibit312q22024.htm	Edgar Link	pending
exhibit321q22024.htm	Edgar Link	pending
exhibit322q22024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kfrc-20240630.htm	Edgar Link	pending
kfrc-20240630.xsd	Edgar Link	pending
kfrc-20240630_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kfrc-20240630_cal.xml	Edgar Link	unprocessable
kfrc-20240630_def.xml	Edgar Link	unprocessable
kfrc-20240630_lab.xml	Edgar Link	unprocessable
kfrc-20240630_pre.xml	Edgar Link	unprocessable
kfrc-20240630_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KFRC
KFORCE INC Stock $kfrc

2024 Q3 Form 10-Q Financial Statement

#000093042024000159 Filed on July 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KFRC KFORCE INC Stock $kfrc

2024 Q3 Form 10-Q Financial Statement

#000093042024000159 Filed on July 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KFRC
KFORCE INC Stock $kfrc